Kelly Nichols

Kelly Nichols has a diverse work experience spanning several companies. Kelly started their career as an Intern at Beantown Biotech in 2015 and continued in that role until December 2016. From 2014 to 2017, they also worked as a Certified Teacher at Knowledge Beginnings.

In 2017, Kelly joined Alkermes as a Contractor, and later became a Research Associate I from March 2018 to June 2019. Kelly then stepped up to the role of Research Associate II from June 2019 to November 2021.

Following their time at Alkermes, Kelly joined Immunitas Therapeutics in November 2021 as a Senior Research Associate until March 2023. During their time at Immunitas Therapeutics, they also briefly held the role of Associate Scientist from March to April 2023.

Currently, Kelly is working as a Senior Associate Scientist at Kelonia Therapeutics, starting in June 2023.

Kelly Nichols attended UMass Boston from 2013 to 2017, where they pursued a Bachelor of Science degree in Biology, with a focus on General Biology.